The 3′ region of the DRD2 gene is involved in genetic susceptibility to schizophrenia

The gene coding for the D2 dopamine receptor (DRD2) is considered as one of the most relevant candidate genes in schizophrenia. Previous genetic studies focusing on this gene yielded conflicting results, for example because of differences in methodology (linkage versus association studies) and variability in the loci analyzed (the DRD2 gene having many polymorphic sites). We used a progressive strategy with two different approaches (case-control and transmission disequilibrium test) and investigated six genetic polymorphisms spanning the DRD2 gene in 103 patients with DSM-IV criteria of schizophrenia, their 206 parents and 83 matched healthy control subjects. We found a significant excess of the A2 allele in subject with schizophrenia compared to unaffected controls. An excess of transmission of the A2 allele (and haplotypes containing this marker) from the parents to the affected children was also observed. Interestingly, the TaqI A1/A2 polymorphism, located 9.5 kb downstream from the DRD2 gene, maps in a novel gene, untitled "X-kinase", and leads to a 713Glu-->Lys substitution in exon 8. As the analysis of the other markers within the DRD2 gene does not improve the strength of the association, our data are in favor of a specific role of the 3' chromosomic region of the DRD2 gene in the vulnerability to schizophrenia.

[1]  S. Dursun,et al.  Treatment resistance in schizophrenia , 2005 .

[2]  D StClair,et al.  -141 C del/ins polymorphism of the dopamine receptor 2 gene is associated with schizophrenia in a British population. , 1999, American journal of medical genetics.

[3]  M. Daly,et al.  High-resolution haplotype structure in the human genome , 2001, Nature Genetics.

[4]  K. Sato,et al.  Polymorphism of dopamine receptors and transporter genes in neuropsychiatric diseases. , 1997, European neurology.

[5]  E. Smeraldi,et al.  No association of the Ser/Cys311 DRD2 molecular variant with schizophrenia using a classical case control study and the haplotype relative risk , 1997, Schizophrenia Research.

[6]  H. Hwu,et al.  No association of dopamine D2 receptor molecular variant Cys311 and schizophrenia in Chinese patients. , 1996, American journal of medical genetics.

[7]  D. Grandy,et al.  The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. , 1989, American journal of human genetics.

[8]  A J Pakstis,et al.  Evolution of haplotypes at the DRD2 locus. , 1995, American journal of human genetics.

[9]  Yuhei Nakamura,et al.  Functional polymorphism of −141C Ins/Del in the dopamine D2 receptor gene promoter and schizophrenia , 1998, Psychiatry Research.

[10]  J. Joven,et al.  Association study of schizophrenia with polymorphisms at six candidate genes , 2001, Schizophrenia Research.

[11]  M. Itokawa,et al.  Further association study on dopamine D2 receptor variant S311C in schizophrenia and affective disorders. , 1996, American journal of medical genetics.

[12]  L. Amaducci,et al.  No evidence of linkage between schizophrenia and D2 dopamine receptor gene locus in Italian pedigrees , 1996, Neuroscience Letters.

[13]  R. Fukuda,et al.  Mismatch PCR RFLP detection of DRD2 Ser311Cys polymorphism and schizophrenia. , 1994, Biochemical and biophysical research communications.

[14]  T. d'Amato,et al.  Association study between dopamine D1, D2, D3, and D4 receptor genes and schizophrenia defined by several diagnostic systems , 1996, Biological Psychiatry.

[15]  P. Patel,et al.  Association between genetic variation at the porphobilinogen deaminase gene and schizophrenia , 1993, Schizophrenia Research.

[16]  E. Thompson,et al.  The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes. , 1988, American journal of human genetics.

[17]  T. Arinami,et al.  Association between a polymorphism in the promoter region of the dopamine D2 receptor gene and schizophrenia in Japanese subjects: replication and evaluation for antipsychotic-related features. , 1999, The international journal of neuropsychopharmacology.

[18]  Frank Dudbridge,et al.  Haplotype tagging for the identification of common disease genes , 2001, Nature Genetics.

[19]  N Risch,et al.  The Future of Genetic Studies of Complex Human Diseases , 1996, Science.

[20]  P Kocsis,et al.  The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. , 1991, JAMA.

[21]  K. Blum,et al.  No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresis. , 1994, JAMA.

[22]  T. Arinami,et al.  A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. , 1997, Human molecular genetics.

[23]  T. d'Amato,et al.  No major role for the dopamine D2 receptor Ser → Cys311 mutation in schizophrenia , 1994, Psychiatric genetics.

[24]  E. Gershon,et al.  Allelic variation in the D4 dopamine receptor (DRD4) gene does not predict response to clozapine. , 1994, Archives of general psychiatry.

[25]  Teresa Tallerico,et al.  Dopamine D2 receptor promoter polymorphism: no association with schizophrenia , 1999, Psychiatry Research.

[26]  P. Gorwood,et al.  Association and excess of transmission of a DRD2 haplotype in a sample of French schizophrenic patients. , 2001, Schizophrenia Research.

[27]  D. Collier,et al.  DRD2 Ser311/Cys311 polymorphism in schizophrenia , 1994, The Lancet.

[28]  J. Gelernter,et al.  D2 Dopamine Receptor Gene (DRD2) Allele and Haplotype Frequencies in Alcohol Dependent and Control Subjects: No Association with Phenotype or Severity of Phenotype , 1999, Neuropsychopharmacology.

[29]  J. Nurnberger,et al.  Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. , 1994, Archives of general psychiatry.

[30]  P. Seeman,et al.  The absolute density of neurotransmitter receptors in the brain. Example for dopamine receptors. , 1987, Journal of pharmacological methods.

[31]  M. Gill,et al.  European Multicentre Association Study of Schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms. , 1998, American journal of medical genetics.

[32]  R. Bradley,et al.  Dopamine DRD2/Cys311 is not associated with chronic schizophrenia. , 1996, American journal of medical genetics.

[33]  K. Kidd,et al.  Transmission/disequilibrium tests using multiple tightly linked markers. , 2000, American journal of human genetics.

[34]  S. Tsuji,et al.  Lack of association between dopamine D2 receptor gene Cys311 variant and schizophrenia. , 1996, American journal of medical genetics.

[35]  Hongyu Zhao,et al.  A global survey of haplotype frequencies and linkage disequilibrium at the DRD2 locus , 1998, Human Genetics.

[36]  D. Grandy,et al.  Detection and characterization of additional DNA polymorphisms in the dopamine D2 receptor gene. , 1991, Genomics.

[37]  J. Lieberman,et al.  No evidence for association of dopamine D2 receptor variant (Ser311/Cys311) with major psychosis. , 1996, American journal of medical genetics.

[38]  S. Smerdon,et al.  The ankyrin repeat: a diversity of interactions on a common structural framework. , 1999, Trends in biochemical sciences.

[39]  J. Gilbert,et al.  SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease. , 2000, American journal of human genetics.

[40]  T. Shinkai,et al.  Association analysis between two functional dopamine D2 receptor gene polymorphisms and schizophrenia. , 2001, American journal of medical genetics.

[41]  M. Leboyer,et al.  Gender and age at onset in schizophrenia: impact of family history. , 1995, The American journal of psychiatry.

[42]  S. Cichon,et al.  Lack of association between schizophrenia and alleles of the dopamine D1, D2, D3 and D4 receptor loci1 , 1993 .

[43]  M. Kaneshima,et al.  An association study between the Cys311 variant of dopamine D2 receptor gene and schizophrenia in the Okinawan population , 1997, Psychiatry and clinical neurosciences.

[44]  R. Hitzemann.  The regulation of D2 dopamine receptor expression , 1998, Molecular Psychiatry.

[45]  S. Cichon,et al.  Dopamine D2 receptor molecular variant and schizophrenia , 1994, The Lancet.

[46]  M. Itokawa,et al.  Association of dopamine D2 receptor molecular variant with schizophrenia , 1994, The Lancet.

[47]  W. Ewens,et al.  Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). , 1993, American journal of human genetics.

[48]  G. Sedvall,et al.  A search for association between schizophrenia and dopamine-related alleles , 2005, European Archives of Psychiatry and Clinical Neuroscience.

[49]  K. Ohara,et al.  Polymorphisms of dopamine D2-like (D2, D3, and D4) receptors in schizophrenia , 1996, Biological Psychiatry.

[50]  Markus M Nöthen,et al.  Association between a promoter polymorphism in the dopamine D2 receptor gene and schizophrenia , 1999, Schizophrenia Research.

[51]  P. Riederer,et al.  Insertion/deletion variant (−141C Ins/Del) in the 5′ regulatory region of the dopamine D2 receptor gene: lack of association with schizophrenia and bipolar affective disorder , 1998, Journal of Neural Transmission.

[52]  H. Yoneda,et al.  The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and −141C Ins/Del polymorphisms , 2002, Psychiatry and clinical neurosciences.

[53]  G. Abecasis,et al.  A general test of association for quantitative traits in nuclear families. , 2000, American journal of human genetics.

[54]  A. Serretti,et al.  Dopamine receptor D2 Ser/Cys 311 variant is associated with delusion and disorganization symptomatology in major psychoses , 2000, Molecular Psychiatry.

[55]  L. Heston,et al.  S311C D2DR variant: no association with schizophrenia , 1994, The Lancet.

[56]  W J Ewens,et al.  The TDT and other family-based tests for linkage disequilibrium and association. , 1996, American journal of human genetics.

[57]  D. Collier,et al.  Case-control, haplotype relative risk and transmission disequilibrium analysis of a dopamine D2 receptor functional promoter polymorphism in schizophrenia , 1998, Schizophrenia Research.

[58]  M. Itokawa,et al.  A structural polymorphism of human dopamine D2 receptor, D2(Ser311-->Cys). , 1993, Biochemical and biophysical research communications.